Who are Viridian Therapeutics, Inc.'s main suppliers?

Viridian Therapeutics, Inc. (VRDN) key suppliers include: WUXI-BIOLOGICS-HONG-KONG-LIMITED, Xencor, Inc.. View the full supplier network at chainsifter.com/chain/VRDN.

Who are Viridian Therapeutics, Inc.'s major customers?

Viridian Therapeutics, Inc. (VRDN) key customers include: ZAI-LAB, ZENAS-BIOPHARMA. View the full customer network at chainsifter.com/chain/VRDN.

What sector is Viridian Therapeutics, Inc. in?

Viridian Therapeutics, Inc. (VRDN) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

VRDN Supply Chain: Viridian Therapeutics, Inc. Suppliers & Customers

2Suppliers

2Customers

3Debt Items

20Related Chains

Viridian Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
WUXI-BIOLOGICS-HONG-KONG-LIMITED	WUXI-BIOLOGICS-HONG-KONG-LIMITED	92%	WuXi Biologics will manufacture and supply the Company’s anticipated long-term supply requirements of veligrotug drug substance and drug product for commercial use
XNCR	Xencor, Inc.	72%	Reciprocal relationship from XNCR graph: Reciprocal relationship from VRDN graph: Reciprocal relationship from XNCR graph: these consolidated financial statements. 77 Xencor, Inc. Notes to Consolidat…

Viridian Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
ZAI-LAB	ZAI-LAB	90%	In August 2025, the Company entered into a material transfer agreement (the “MTA”) with Zai Lab, to supply certain materials for clinical trial use in exchange for a fixed payment.
ZENAS-BIOPHARMA	ZENAS-BIOPHARMA	80%	The Side Agreement and MTA were evaluated under ASC 606, Revenue from Contracts with Customers, and determined to be contract modifications to the Zenas Agreements.

Viridian Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
VRDN-DEBT-13423	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.
VRDN-DEBT	Debt stack $53.4M	90%	Market cache reports total debt of $53.4M.
VRDN-DEBT-13422	Warrants outstanding: 7535815	90%	xbrl warrant detail from xbrl 2025-12-31.

Viridian Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Viridian Therapeutics, Inc..

Viridian Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
VRDN-OWNER-FMR-LLC	FMR LLC	90%	13F overlay lists FMR LLC as top holder; 227 tracked holders.

Viridian Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
BCYC	Bicycle Therapeutics plc	100.00	2
ALC	Alcon Inc.	100.00	2
CSTE	Caesarstone Ltd.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
DYN	Dyne Therapeutics, Inc.	100.00	2
SNNUF	Smith & Nephew plc	100.00	2
CLYM	Climb Bio, Inc.	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
AORT	Artivion, Inc.	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
BNBX	BNB Plus Corp.	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
ANIK	Anika Therapeutics, Inc.	100.00	2
DNTH	Dianthus Therapeutics, Inc.	100.00	2
BNR	Burning Rock Biotech Limited	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
PSNL	Personalis, Inc.	100.00	2
AZN	AstraZeneca PLC	100.00	2
BHC	Bausch Health Companies Inc.	100.00	2

Viridian Therapeutics, Inc. Supply Chain